Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Steve Harmon who wrote (2307)	6/9/1999 3:31:00 PM
From: Walter Morton	Read Replies (1) \| Respond to of 2742

HMGN has taken off since Genome Securties posted the For Sale/For Merger sign on CIST. In a telephone conversation today, I was told that at least one Genome representative has visited HMGN to discuss possibilities. However, in the same a telephone conversation, a representative of Genome Securities made it clear to me that Genome does not believe that HMGN is the vehicle that CIST shareholders would want.

To: Steve Harmon who wrote (2307)	6/17/1999 4:06:00 AM
From: Walter Morton	Read Replies (1) \| Respond to of 2742

Reasons for Mergers synergy growth accelerate growth leverage vertical integration increase product lines, depth, width gain market share gain international exposure gain international market share gain a niche market diversification increase return on investment increase return on assets increase return on equity publicity need for new leadership/management facing bankruptcy under bankruptcy easier than starting a new entity increase efficiency politics/contacts